REGISTERED NUMBER: SC546389 (Scotland)

Unaudited Financial Statements for the Year Ended 31 October 2025

for

Glasgow Neuroradiology Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr Ravi Jampana

Mrs Sri V Jampana

Saketh V Jampana

SECRETARY:

Mrs Sri V Jampana

REGISTERED OFFICE:

17 Mearnswood Place

Newton Mearns

Glasgow

G77 6BF

REGISTERED NUMBER:

SC546389 (Scotland)

ACCOUNTANTS:

Stevenson & Kyles

Chartered Accountants

25 Sandyford Place

Glasgow

G3 7NG

FIXED ASSETS

Tangible assets

4

21,751

29,002

CURRENT ASSETS

Debtors

5

23,117

24,368

Cash at bank

197,835

116,011

220,952

140,379

CREDITORS

Amounts falling due within one year

6

185,829

166,689

NET CURRENT ASSETS/(LIABILITIES)

35,123

(26,310

)

TOTAL ASSETS LESS CURRENT LIABILITIES

56,874

2,692

PROVISIONS FOR LIABILITIES

7

4,133

1,766

NET ASSETS

52,741

926

CAPITAL AND RESERVES

Called up share capital

8

100

100

Retained earnings

52,641

826

SHAREHOLDERS' FUNDS

52,741

926

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:

Dr Ravi Jampana - Director

1.	STATUTORY INFORMATION

Glasgow Neuroradiology Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fittings and equipment

-

25% on reducing balance

Motor vehicles

-

25% on reducing balance

Financial instruments

Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Grant income

Where applicable, grants from the government are recognised at their fair value where there is a reasonable assurance that the grant will be received and that the company will comply with all attached conditions. Where the grant income relates to a particular expense item, the grant income is recognised in the profit and loss account over the same period as the expense it is intended to compensate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Fittings

and

Motor

equipment

vehicles

Totals

£

£

£

COST

At 1 November 2024

and 31 October 2025

5,797

29,662

35,459

DEPRECIATION

At 1 November 2024

2,749

3,708

6,457

Charge for year

762

6,489

7,251

At 31 October 2025

3,511

10,197

13,708

NET BOOK VALUE

At 31 October 2025

2,286

19,465

21,751

At 31 October 2024

3,048

25,954

29,002

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

22,316

23,567

Other debtors

801

801

23,117

24,368

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

34,459

-

Other creditors

151,370

166,689

185,829

166,689

7.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

4,133

1,766

Deferred

tax

£

Balance at 1 November 2024

1,766

Provided during year

2,367

Balance at 31 October 2025

4,133

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

80

A Ordinary

£1

80

80

10

B Ordinary

£1

10

10

10

C Ordinary

£1

10

10

100

100